LifeMD Inc expected to post a loss of 15 cents a share - Earnings Preview

LifeMD

03/08/2026 23:31

LifeMD Inc LFMD.OQ LFMD.O is expected to  show a fall in quarterly revenue when it reports  results on August 5 for the period ending June 30 2026
The New York City-based  company is expected to report a 21.0% decrease in revenue to $49.152 million from $62.22 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.The company's guidance on May 6 2026, for the period ended June 30, was for revenue between $47.00 million and $50.00 million.
​LSEG's mean analyst estimate for LifeMD Inc is for a loss of 15 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for LifeMD Inc is $10.00, about 168.1% above its last closing price of $3.73
The company's guidance on May 6 2026 for the period ended June 30 was for Earnings before Interest, Taxes, Depreciation and Amortization of between 47 million and 1 million (USD).
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.23
-0.22
-0.20
Beat
9.9
Dec. 31 2026
-0.06
-0.03
-0.04
Missed
-20
Sep. 30 2025
-0.05
-0.05
-0.07
Missed
-50​
Jun. 30 2025
0.01
-0.01
-0.06
Missed
-650
​​Mar. 31 2025
-0.06
-0.05
0.01
Beat
118.9
Dec. 31 2024
-0.07
-0.05
-0.02
Beat
61.1​
Sep. 30 2024
-0.12
-0.12
-0.14
Missed
-18
Jun. 30 2024
-0.14
-0.12
-0.19
Missed
-52
This summary was machine generated August 3 at 22:30 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)